MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

FDA gives Vetter the green light

Release issued 27th February 2008

Vetter, which provides contract manufacturing services for pharmaceutical and biotech companies, will now begin filling an innovative drug at its Ravensburg Vetter South (RVS) facility. The latest FDA client product approval underscores the competence of the world leader in aseptically pre-filled injection systems used in the production of biotechnological and complex medications.

 

"For us, the approval by the Food and Drug Administration is a vital step in our corporate development," said Thomas Otto, Vetter’s Managing Director. “It means that we can continue expanding our business. It also secures our jobs, our investments and our future projects. In addition, it reinforces our position as an expert in the filling of sensitive substances.” Vetter currently has a staff of about 1,900. The company works for numerous international pharmaceutical and biotech firms. Vetter has already passed several FDA inspections with excellent marks.

 

About Vetter Pharma-Fertigung GmbH & Co. KG:
Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. With about 1,900 employees worldwide, Vetter holds nearly 140 patents and has longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. In 2007 the company also received the go-ahead as a foreign manufacturer for the Japanese pharmaceutical market from Japan’s Ministry for Health, Labor and Welfare. Additionally, Vetter has received two awards for its new facility Ravensburg Vetter South (RVS): The Facility of the Year Award 2007 (Process Innovation category) and the European Outsourcing Award 2007 (Most Improved Process/Plant/Facility category).

 

Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions’ patented application systems enable clients to compete more effectively throughout the world.

 

Contact

Vetter Pharma-Fertigung GmbH & Co. KG

Suzan Frohmann

Schuetzenstrasse 87

88212 Ravensburg

Phone: (0751) 3700 - 0

Fax: (0751) 3700 - 40 00

E-Mail: info@vetter-pharma.com

www.vetter-pharma.com

 

Company details

If you want to find out more about the company visit Vetter Pharma International GmbH profile.

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us